Quanterix Corp

QTRX · XNAS

CIK 1503274fmd_0QTFTEC6SK4AYHZGFDSRYF84FWManufacturing · Laboratory Analytical InstrumentsTemplate: Standard

Coverage: Jan 01, 2016 to Sep 30, 2026, 40 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	18	23	38	57	86	111	106	122	137	139
Cost of revenue	10	13	20	30	38	46	60	48	54	74
Net interest income	(1)	(1)	0	1	(0)	(0)	5	16	15	9
Gross profit	8	10	18	27	48	65	45	74	83	65
Provision for credit losses	–	–	–	–	0	0	1	1	1	1
Research and development	17	16	16	16	20	28	27	26	31	36
Net interest income after provision	–	–	–	–	(1)	(1)	4	15	14	7
Selling, general and administrative	12	20	34	52	60	93	92	89	102	138
Total operating expenses	29	36	49	68	80	121	150	120	136	191
Operating income	(22)	(26)	(32)	(42)	(32)	(57)	(104)	(46)	(53)	(126)
Other non-operating income (expense)	(0)	(0)	(0)	(0)	(0)	1	(0)	3	(0)	0
Income before taxes	(23)	(27)	(32)	(41)	(32)	(56)	(99)	(28)	(38)	(112)
Income tax expense	–	0	0	(0)	(0)	(0)	0	1	0	(5)
Net income from continuing operations	–	(27)	(32)	(41)	(32)	(56)	(100)	(28)	(39)	(107)
Net income	(23)	(27)	(32)	(41)	(32)	(56)	(100)	(28)	(39)	(107)
Net income to common shareholders	(28)	(31)	(32)	(41)	–	–	–	–	–	–